Introduction
Factors contributing to the increasing incidence of diabetes include sedentary lifestyle, obesity and population ageing.1 In this regard, the disease has been associated with a poorer quality of life, physical inactivity, obesity and other comorbidities, as well as to non-modifiable factors such as advanced age and male sex.2
Diabetic mellitus (DM) is a chronic disease that constitutes a considerable public health problem, negatively impacting on patients’ quality of life and influencing healthcare policy.2 3 The worldwide prevalence of diabetes and impaired glucose tolerance in adults has increased in the past few decades.2 4 5 According to recent estimates by the International Diabetes Federation, in 2019, there were 463 million people living with diabetes worldwide (9.3% of adults aged between 18 years and 99 years), and this figure is set to reach 578 million (10.2%) by 2030 and 700 million (10.9%) by 2045.5 Moreover, half of people with diabetes (50.1%) are undiagnosed.5 This high prevalence has important social, financial and developmental repercussions, particularly in low-income and middle-income countries.6 Diabetes is among the 10 leading causes of death in adults, and was responsible for an estimated 4.2 million deaths worldwide in 2019.5 As a result, the impact of diabetes on healthcare systems and national economies is of increasing concern. In 2019, the global healthcare expenditure linked to diabetes was US$760 billion, and this sum is projected to reach 825 billion by 2030 and 845 billion by 2045.5
The main social repercussions of diabetes are related to use of healthcare and social resources, as the medical costs of diabetes patients are three times that of people without the disease.7–9 In addition, the increase in prevalence, combined with the increase in medical cost per capita, suggests that the burden of diabetes on health systems will continue to increase.10 This disease represents a public health challenge as it requires more efficient social and healthcare strategies. This justifies analysis of healthcare use among patients with diabetes, with a view to guiding health policies and ensuring appropriate allocation of healthcare resources.9
The costs traditionally associated with diabetes include medical visits, emergency care, hospitalisation and medicines,11 and various studies have shown that the presence of complications and hospital admission are the main cost factors.9 12–14 Indeed, costs associated with hospitalisation account for more than two-thirds of the total costs attributable to diabetes.8 14–16 People with diabetes are at increased risk of hospitalisation because of macrovascular complications (eg, coronary artery, cerebrovascular and peripheral vascular disease) and microvascular complications (eg, retinopathy, nephropathy and neuropathy).17 18 Within this population, type 2 DM accounts for 90% of all cases of DM19 and is usually managed in primary care settings, saving many of these costs. For example, a larger UK-enhanced primary care-based DM cost comparison analysis confirms significant cost savings, likely driven by economies of scale.20 Hence, these benefits could be multiplied if services are implemented at a nationwide level.
Although the universal healthcare model predominates in Europe, people with diabetes show different patterns of healthcare use, depending on their level of education or economic status.21 22 Low socioeconomic status has been associated with a higher incidence of diabetes,7 poorer healthcare, worse management of complications and greater use of healthcare services.21–23 To achieve greater health equity, it is crucial to measure and interpret the socioeconomic inequalities related to health and healthcare.8 16 22 To date, however, there is a lack of published research on healthcare use in people with diabetes,24 and most studies do not take into account healthcare use indirectly attributable to the disease (eg, for mental health comorbidities in the diabetic population).25
To harmonise health data and obtain common indicators, the European Union (EU) statistical office (Eurostat) decided to implement the European Health Interview Survey (EHIS). Thus far, no published studies have used EHIS data to analyse indicators of health and healthcare use in people with diabetes. This study aims to determine how health determinants, lifestyle and socioeconomic variables relate to healthcare use (primary care visits and hospital admissions) in people with diabetes in Europe.